Literature DB >> 17259505

Should central obesity be an optional or essential component of the metabolic syndrome? Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study.

Jeannette Lee1, Stefan Ma, Derrick Heng, Chee-Eng Tan, Suok-Kai Chew, Kenneth Hughes, E-Shyong Tai.   

Abstract

OBJECTIVE: The International Diabetes Federation (IDF) proposes that central obesity is an "essential" component of the metabolic syndrome, while the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) proposes that central obesity is an "optional" component. This study examines the effect of the metabolic syndrome with and without central obesity in an Asian population with ischemic heart disease (IHD). RESEARCH DESIGN AND METHODS: From the population-based cohort study (baseline 1992-1995), 4,334 healthy individuals were grouped by the presence or absence of the metabolic syndrome and central obesity and followed up for an average of 9.6 years by linkage with three national registries. Cox's proportional hazards model was used to obtain adjusted hazard ratios (HRs) for risk of a first IHD event.
RESULTS: The prevalence of metabolic syndrome was 17.7% by IDF criteria and 26.2% by AHA/NHLBI criteria using Asian waist circumference cutoff points for central obesity. Asian Indians had higher rates than Chinese and Malays. There were 135 first IHD events. Compared with individuals without metabolic syndrome, those with central obesity/metabolic syndrome and no central obesity/metabolic syndrome were at significantly increased risk of IHD, with adjusted HRs of 2.8 (95% CI 1.8-4.2) and 2.5 (1.5-4.0), respectively.
CONCLUSIONS: Having metabolic syndrome either with or without central obesity confers IHD risk. However, having central obesity as an "optional" rather than "essential" criterion identifies more individuals at risk of IHD in this Asian cohort.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259505     DOI: 10.2337/dc06-1866

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  19 in total

1.  [Randomised controlled trial: the role of diet and exercise in women with metabolic syndrome].

Authors:  Pedro Enrique Miguel Soca; Idania Peña Pérez; Silvio Niño Escofet; Walter Cruz Torres; Aluett Niño Peña; Delmis Ponce De León
Journal:  Aten Primaria       Date:  2011-11-08       Impact factor: 1.137

2.  Effect of metabolic syndrome components and their clustering on carotid atherosclerosis in a sample of the general Japanese population.

Authors:  Chiaki Hirata; Nobuyuki Miyai; Ayaka Idoue; Miyoko Utsumi; Sonomi Hattori; Akihiko Iwahara; Yuji Uematsu; Mitsuru Shiba; Mikio Arita
Journal:  Hypertens Res       Date:  2016-01-21       Impact factor: 3.872

3.  Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases.

Authors:  Yan Feng; Xiumei Hong; Elissa Wilker; Zhiping Li; Wenbin Zhang; Delai Jin; Xue Liu; Tonghua Zang; Xiping Xu; Xin Xu
Journal:  Atherosclerosis       Date:  2007-08-06       Impact factor: 5.162

4.  The effectiveness of IDF and ATP-III in identifying metabolic syndrome and the usefulness of these tools for health-promotion in older Taiwanese.

Authors:  M M Chen; A C Tsai
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

5.  The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing Metabolic Syndrome among Malays in Kuala Lumpur.

Authors:  Foong Ming Moy; Awang Bulgiba
Journal:  BMC Public Health       Date:  2010-11-06       Impact factor: 3.295

6.  Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men.

Authors:  E S Tai; M L S Tan; R D Stevens; Y L Low; M J Muehlbauer; D L M Goh; O R Ilkayeva; B R Wenner; J R Bain; J J M Lee; S C Lim; C M Khoo; S H Shah; C B Newgard
Journal:  Diabetologia       Date:  2010-01-15       Impact factor: 10.122

7.  Metabolic syndrome among Sri Lankan adults: prevalence, patterns and correlates.

Authors:  Prasad Katulanda; Priyanga Ranasinghe; Ranil Jayawardana; Rezvi Sheriff; David R Matthews
Journal:  Diabetol Metab Syndr       Date:  2012-05-31       Impact factor: 3.320

8.  Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study.

Authors:  I-Te Lee; Yen-Feng Chiu; Chii-Min Hwu; Chih-Tsueng He; Fu-Tien Chiang; Yu-Chun Lin; Themistocles Assimes; J David Curb; Wayne H-H Sheu
Journal:  Cardiovasc Diabetol       Date:  2012-04-26       Impact factor: 9.951

9.  A comparison of predictability of cardiovascular events between each metabolic component in patients with metabolic syndrome based on the revised National Cholesterol Education Program criteria.

Authors:  In-Cheol Hwang; Kyoung-Kon Kim; Sun-Ha Jee; Hee-Cheol Kang
Journal:  Yonsei Med J       Date:  2011-03       Impact factor: 2.759

10.  Metabolic syndrome & Framingham Risk Score: observations from a coronary angiographic study in Indian patients.

Authors:  Roopali Khanna; Aditya Kapoor; Sudeep Kumar; Satyendra Tewari; Naveen Garg; Pravin K Goel
Journal:  Indian J Med Res       Date:  2013-02       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.